Literature DB >> 9362326

Positional cloning of the PEX gene: new insights into the pathophysiology of X-linked hypophosphatemic rickets.

M J Econs1, F Francis.   

Abstract

X-linked hypophosphatemic rickets (HYP) is the most common form of hereditary renal phosphate wasting. The hallmarks of this disease are isolated renal phosphate wasting with inappropriately normal calcitriol concentrations and a mineralization defect in bone. Studies in the Hyp mouse, one of the murine models of the human disease, suggest that there is an approximately 50% decrease in both message and protein of NPT-2, the predominant sodium-phosphate cotransporter in the proximal tubule. However, human NPT-2 maps to chromosome 5q35, indicating that it is not the disease gene. Positional cloning studies have led to the identification of a gene, PEX, which is responsible for the disorder. Further studies have led to identification of the murine Pex gene, which is mutated in the murine models of the disorder. These studies, in concert with other studies, have led to improved understanding of the pathophysiology of HYP and a new appreciation for the complexity of normal phosphate homeostasis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9362326     DOI: 10.1152/ajprenal.1997.273.4.F489

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

Review 1.  Familial hypophosphatemia: an unusual presentation with low back ache, heel pain, and a limp in a young man, and literature review.

Authors:  Sharon Arthur; Arvind Chopra
Journal:  Clin Rheumatol       Date:  2010-11-02       Impact factor: 2.980

2.  FGF2 High Molecular Weight Isoforms Contribute to Osteoarthropathy in Male Mice.

Authors:  Patience Meo Burt; Liping Xiao; Caroline Dealy; Melanie C Fisher; Marja M Hurley
Journal:  Endocrinology       Date:  2016-10-12       Impact factor: 4.736

3.  Sustained Klotho delivery reduces serum phosphate in a model of diabetic nephropathy.

Authors:  Julia M Hum; Linda M O'Bryan; Arun K Tatiparthi; Erica L Clinkenbeard; Pu Ni; Martin S Cramer; Manoj Bhaskaran; Robert L Johnson; Jonathan M Wilson; Rosamund C Smith; Kenneth E White
Journal:  J Appl Physiol (1985)       Date:  2019-01-03

4.  Inhibition of FGFR Signaling Partially Rescues Osteoarthritis in Mice Overexpressing High Molecular Weight FGF2 Isoforms.

Authors:  Liping Xiao; Donyell Williams; Marja M Hurley
Journal:  Endocrinology       Date:  2020-01-01       Impact factor: 4.736

5.  FGF receptor inhibitor BGJ398 partially rescues osteoarthritis-like phenotype in older high molecular weight FGF2 transgenic mice via multiple mechanisms.

Authors:  Marja M Hurley; J Douglas Coffin; Thomas Doetschman; Christina Valera; Kai Clarke; Liping Xiao
Journal:  Sci Rep       Date:  2022-09-24       Impact factor: 4.996

6.  Fibroblast Growth Factor 2 High Molecular Weight Isoforms in Dentoalveolar Mineralization.

Authors:  Grethel Millington; Johnny Joseph; Liping Xiao; Anushree Vijaykumar; Mina Mina; Marja M Hurley
Journal:  Calcif Tissue Int       Date:  2021-07-10       Impact factor: 4.333

7.  Hypophosphatemic Rickets in Siblings: A Rare Case Report.

Authors:  Gummadapu Sarat; Nuthalapati Priyanka; Meka Purna Venkata Prabhat; Chintamaneni Raja Lakshmi; Sujana Mulk Bhavana; Dharmavaram Ayesha Thabusum
Journal:  Case Rep Dent       Date:  2016-05-31

8.  Two novel variants of the PHEX gene in patients with X‑linked dominant hypophosphatemic rickets and prenatal diagnosis for fetuses in these families.

Authors:  Hong Liao; Hong-Mei Zhu; Hong-Qian Liu; Ling-Ping Li; Shan-Ling Liu; He Wang
Journal:  Int J Mol Med       Date:  2018-01-18       Impact factor: 4.101

Review 9.  Rickets in Children: An Update.

Authors:  Cristina Gentile; Francesco Chiarelli
Journal:  Biomedicines       Date:  2021-06-27

Review 10.  Cellular and Molecular Alterations Underlying Abnormal Bone Growth in X-Linked Hypophosphatemia.

Authors:  Rocío Fuente; María García-Bengoa; Ángela Fernández-Iglesias; Helena Gil-Peña; Fernando Santos; José Manuel López
Journal:  Int J Mol Sci       Date:  2022-01-15       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.